Hodgkin's Lymphoma

Hodgkin's lymphoma, previously known as Hodgkin's disease, is a type of lymphoma, which is a type of cancer originating from white blood cells called lymphocytes. It was named after Thomas Hodgkin, who first described abnormalities in the lymph system in 1832.
What is Hodgkin's Lymphoma?

Hodgkin’s lymphoma or Hodgkin’s disease is a form of cancer that affects the lymphatic system. The cancer originates in the lymphocytes, which are white blood cells. The disease was so named after Thomas Hodgkin, who first described the condition in 1832.

Read More

Overview

Feature Articles

Latest Hodgkin's Lymphoma News and Research

Novel radioimmunotherapy proven effective in reversing resistance to lymphoma therapy

Novel radioimmunotherapy proven effective in reversing resistance to lymphoma therapy

Calibr's novel 'switchable' CAR-T cell therapy granted FDA's Fast Track designation

Calibr's novel 'switchable' CAR-T cell therapy granted FDA's Fast Track designation

Study explores link between personal use of hair dyes and cancer risk

Study explores link between personal use of hair dyes and cancer risk

FDA provides update on adverse events associated with breast implants

FDA provides update on adverse events associated with breast implants

New cancer vaccine shows promising signs in preclinical studies

New cancer vaccine shows promising signs in preclinical studies

Innovent Biologics and MD Anderson to develop sintilimab injection for rare cancers

Innovent Biologics and MD Anderson to develop sintilimab injection for rare cancers

People with a cancer history have increased risk of developing atrial fibrillation

People with a cancer history have increased risk of developing atrial fibrillation

CD19 CAR NK cell therapy clinical trial shows encouraging results for hematologic cancers

CD19 CAR NK cell therapy clinical trial shows encouraging results for hematologic cancers

UAB seminar on the extraordinary science of the immune system

UAB seminar on the extraordinary science of the immune system

Young patients with IBD have increased risk of severe viral infections

Young patients with IBD have increased risk of severe viral infections

Eisai transfers rights to Royalty Pharma relating to net sales of EZH2 inhibitor outside of Japan

Eisai transfers rights to Royalty Pharma relating to net sales of EZH2 inhibitor outside of Japan

Molecular mechanisms involved in Pixantrone's interactions with cancer DNA discovered

Molecular mechanisms involved in Pixantrone's interactions with cancer DNA discovered

Phase 2 clinical trial of CAR T-cell therapy starts at Atlantic Health System

Phase 2 clinical trial of CAR T-cell therapy starts at Atlantic Health System

Patients with non-Hodgkin's lymphoma may benefit from radiation, experience reduced side effects

Patients with non-Hodgkin's lymphoma may benefit from radiation, experience reduced side effects

Innovative technology could help treat cancer more selectively and effectively

Innovative technology could help treat cancer more selectively and effectively

Innovative technology could treat cancer more selectively and effectively

Innovative technology could treat cancer more selectively and effectively

Scientists discover novel mechanism of action for NK cells in checkpoint inhibitor for cancer

Scientists discover novel mechanism of action for NK cells in checkpoint inhibitor for cancer

Chemotherapy can wreak havoc on the heart

Chemotherapy can wreak havoc on the heart

Cancer patients share survivorship story, celebrate strength and self-care

Cancer patients share survivorship story, celebrate strength and self-care

Researchers identify important signaling molecule in the biology of Hodgkin's lymphoma

Researchers identify important signaling molecule in the biology of Hodgkin's lymphoma